VF
MRVI icon

Virtu Financial’s Maravai LifeSciences MRVI Stock Holding History

Virtu Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,309
Closed -$34K – 2045
2025
Q4 		$34K Buy
+10,309
New +$34.7K ﹤0.01% 1346
2024
Q1 		– Sell
-20,723
Closed -$136K – 1832
2023
Q4 		$136K Buy
+20,723
New +$134K 0.01% 954
2022
Q2 		– Sell
-35,042
Closed -$1.24M – 1883
2022
Q1 		$1.24M Buy
+35,042
New +$1.17M 0.09% 185
2021
Q3 		– Sell
-9,631
Closed -$402K – 1792
2021
Q2 		$402K Buy
9,631
+318
+3% +$12.3K 0.04% 575
2021
Q1 		$332K Sell
9,313
-6,953
-43% -$230K 0.02% 756
2020
Q4 		$456K Buy
+16,266
New +$453K 0.05% 466

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's MRVI Position: Q1 2026 in Review

Virtu Financial sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 10,309 shares — an estimated $34K sold.

Virtu Financial first reported a position in MRVI in Q4 2020 and held it in 6 quarters. The position peaked at $1.24M in Q1 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Virtu Financial reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,309 Maravai LifeSciences shares in Q1 2026, an estimated $34K.
  • Virtu Financial first reported a position in Maravai LifeSciences in Q4 2020 and held it in 6 quarters.
  • Virtu Financial's Maravai LifeSciences position peaked at $1.24M in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.